SG11202107531PA - Method for preparation of 1,4-sorbitan in aqueous medium - Google Patents
Method for preparation of 1,4-sorbitan in aqueous mediumInfo
- Publication number
- SG11202107531PA SG11202107531PA SG11202107531PA SG11202107531PA SG11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA SG 11202107531P A SG11202107531P A SG 11202107531PA
- Authority
- SG
- Singapore
- Prior art keywords
- sorbitan
- preparation
- aqueous medium
- aqueous
- medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019071900 | 2019-01-16 | ||
| US201962799821P | 2019-02-01 | 2019-02-01 | |
| EP19154950 | 2019-02-01 | ||
| EP19157025 | 2019-02-13 | ||
| EP19157027 | 2019-02-13 | ||
| PCT/EP2020/051059 WO2020148404A1 (en) | 2019-01-16 | 2020-01-16 | Method for preparation of 1,4-sorbitan in aqueous medium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202107531PA true SG11202107531PA (en) | 2021-08-30 |
Family
ID=69190760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107531PA SG11202107531PA (en) | 2019-01-16 | 2020-01-16 | Method for preparation of 1,4-sorbitan in aqueous medium |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220064135A1 (en) |
| EP (1) | EP3911635A1 (en) |
| JP (1) | JP2022518029A (en) |
| KR (1) | KR20210135995A (en) |
| CN (1) | CN113330002A (en) |
| CA (1) | CA3126742A1 (en) |
| SG (1) | SG11202107531PA (en) |
| WO (1) | WO2020148404A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020043639A1 (en) * | 2018-08-27 | 2020-03-05 | Lonza Guangzhou Nansha Ltd. | Method for preparation of 1,4-sorbitan |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101948451B (en) * | 2010-08-18 | 2013-03-06 | 南京威尔化工有限公司 | Preparation method of high-purity 1,4-sorbitan |
| CN106167476B (en) * | 2016-07-20 | 2018-01-12 | 广州嘉德乐生化科技有限公司 | A kind of preparation method of Sorbitan Oleate |
-
2020
- 2020-01-16 EP EP20701705.4A patent/EP3911635A1/en not_active Withdrawn
- 2020-01-16 JP JP2021541299A patent/JP2022518029A/en active Pending
- 2020-01-16 CA CA3126742A patent/CA3126742A1/en active Pending
- 2020-01-16 US US17/423,193 patent/US20220064135A1/en active Pending
- 2020-01-16 KR KR1020217024083A patent/KR20210135995A/en active Search and Examination
- 2020-01-16 SG SG11202107531PA patent/SG11202107531PA/en unknown
- 2020-01-16 CN CN202080010466.3A patent/CN113330002A/en active Pending
- 2020-01-16 WO PCT/EP2020/051059 patent/WO2020148404A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020148404A1 (en) | 2020-07-23 |
| EP3911635A1 (en) | 2021-11-24 |
| CA3126742A1 (en) | 2020-07-23 |
| KR20210135995A (en) | 2021-11-16 |
| CN113330002A (en) | 2021-08-31 |
| US20220064135A1 (en) | 2022-03-03 |
| JP2022518029A (en) | 2022-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018001491A (en) | Methods for preparation of bile acids and derivatives thereof. | |
| EP3889152A4 (en) | Heteroaromatic derivatives for use as regulator, preparation method therefor and use thereof | |
| EP3228625A4 (en) | Preparation method for conchiolin, and water-soluble conchiolin and acid-soluble conchiolin prepared by using method | |
| IL286471B1 (en) | Derivatives of phenylisoxazolidine-(pyrimidine-amino-phenyl)-acrylamide, method for their preparation and pharmaceutical composition comprising them | |
| EP3730623A4 (en) | Small-molecule hyaluronic acid or salt thereof, and preparation method therefor | |
| IL276244A (en) | Ophthalmic pharmaceutical composition, preparation method therefor and application thereof | |
| EP3786179A4 (en) | Extracellular-matrix-containing composition, method for producing same, three-dimensional tissue construct, and three-dimensional tissue construct formation agent | |
| IL276430A (en) | Pharmaceutical compound, salts thereof, formulations thereof, and methods of making and using same | |
| EP3530650A4 (en) | Crystalline form of (r)-4-hydroxy-2-oxo-1-pyrrolidineacetamide, preparation method therefor and use thereof | |
| GB202008327D0 (en) | Method for preparing 2,2'dipyridine and derivatives thereof | |
| EP3679919A4 (en) | Skin- or hair-cleaning agent composition containing aqueous gelling agent, and method for producing aqueous gelling agent and cleaning agent composition | |
| SG11202107531PA (en) | Method for preparation of 1,4-sorbitan in aqueous medium | |
| EP3282006A4 (en) | Method for preparing liquid medium composition, and preparation device and kit therefor | |
| EP3530276A4 (en) | Kit for preparing disease-treating agent, disease-treating agent and method for preparing disease-treating agent | |
| EP3902790C0 (en) | Improved method for the preparation of 4,6-dihydroxypyrimidine | |
| EP3964500A4 (en) | Salt of diaminopyrimidine compounds, and solid form thereof, preparation method therefor and use thereof | |
| EP3923983A4 (en) | Chimeric rsv and hmpv f proteins, immunogenic compositions, and methods of use | |
| AR106559A1 (en) | WATERPROOF SUSPENSION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARATION | |
| EP3875595A4 (en) | Liquid medium preparation method | |
| EP3898582A4 (en) | New salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof | |
| EP3805271A4 (en) | Method for preparing sugammadex sodium salt | |
| EP3885333A4 (en) | Production method of 1,2-difluoroethylene | |
| EP3398946A4 (en) | Salt of morpholine derivative and crystalline form thereof, as well as preparation method, pharmaceutical composition and use of the same | |
| HUE055904T2 (en) | Preparation of 2-([1,2,3]triazol-2-yl)-benzoic acid derivatives | |
| EP3357925A4 (en) | Salt type and crystal type of 4h-pyrazolo [1, 5-alpha]benzimidazole compound and preparation method and intermediate thereof |